Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-04-21 @ 4:04 PM
Study NCT ID:
NCT02314169
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-29
First Post:
2014-12-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization: